PCBP2 and hepatocellular carcinoma: Mechanistically, HNF4A-AS1 was found to inhibit the stability of AGR2 mRNA by promoting the proteasomal degradation of PCBP2, thereby participating in the regulation of the malignant phenotype of HCC.